We are live on ! Find out more
BFRA

Biofrontera AG American Depositary Shares

Delisted

BFRA was delisted on the 4th of March, 2022.

7 hedge funds and large institutions have $6.59M invested in Biofrontera AG American Depositary Shares in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

17% more funds holding

Funds holding: 67 (+1)

1.1% less ownership

Funds ownership: 2.81%1.71% (-1.1%)

32% less capital invested

Capital invested by funds: $9.67M → $6.59M (-$3.08M)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

BFRA Hedge Fund Activity: Q3 2018 in Review

7 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Biofrontera AG American Depositary Shares (BFRA) for Q3 2018, worth a combined $6.59M — down 32% from $9.67M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new BFRA positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Deutsche Bank, opening a new position worth an estimated $19K. The largest seller was Opaleye Management, cutting an estimated $4.24M.

  • 7 institutional investors held Biofrontera AG American Depositary Shares (BFRA) as of Q3 2018, up from 6 in Q2 2018.
  • Funds reported $6.59M of Biofrontera AG American Depositary Shares stock for Q3 2018, down 32% quarter-over-quarter.
  • 1 fund opened new Biofrontera AG American Depositary Shares positions in Q3 2018 and 0 closed out, a net change of +1 holder.
  • The largest Biofrontera AG American Depositary Shares buyer in Q3 2018 was Deutsche Bank, an estimated $19K added.
  • The largest Biofrontera AG American Depositary Shares seller in Q3 2018 was Opaleye Management, an estimated $4.24M sold.

Based on aggregated 13F filings for Q3 2018.